Related Experiment Video

Updated: Aug 29, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Thalassemia: the facts and the controversies

Anita J Catlin1

  • 1Sonoma State University, California, USA. acatlin@napanet.net

Pediatric Nursing
|January 28, 2004
PubMed

Insights

Thalassemia treatment in the US faces challenges, with increasing prevalence in diverse pediatric populations. Newborn screening identifies potential cases, prompting further investigation for these red blood cell disorders.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Thalassemia presents ongoing challenges in the United States.
  • Increasing cultural diversity is projected to raise the incidence of thalassemia in pediatric patients.
  • Newborn screening for hemoglobinopathies is standard practice in the US.

Purpose of the Study:

  • To provide an updated overview of thalassemia.
  • To discuss current treatment progress and challenges.
  • To explore ethical considerations in thalassemia care.

Main Methods:

  • Review of current literature on thalassemia.
  • Analysis of newborn screening protocols for hemoglobinopathies.
  • Discussion of ethical dilemmas in patient management.

Main Results:

  • Newborn screening identifies elevated fetal hemoglobin, alpha hemoglobin, or hemoglobin E, indicating potential thalassemia.
  • The article serves as a knowledge refresher on red blood cell diseases.
  • Ethical controversies in thalassemia care are presented.

Conclusions:

  • Continued progress and challenges exist in US thalassemia treatment.
  • Anticipated increase in pediatric thalassemia cases due to demographic shifts.
  • Ethical considerations are crucial in managing thalassemia patients.

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Related Concept Videos

Multiple Allele Traits02:19

Multiple Allele Traits

For the same gene multiple alleles can interact to influence phenotypes like the shape and protein composition of an individual cells.By studying allele interactions on the molecular and cellular levels researchers can understand the resulting phenotypes and complications of human conditions like sickle cell trait, improving treatment.The ABO blood group system is a common example of multiple alleles in humans. This system includes three alleles called IA, IB, and i alleles, which combine in...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...